tiprankstipranks
Soleno Therapeutics (SLNO)
NASDAQ:SLNO
US Market
SLNO
Soleno Therapeutics
RESEARCH TOOLSreports
Want to see SLNO full AI Analyst Report?

Soleno Therapeutics (SLNO) Financial Statements

924 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently ―. The company's EPS TTM is $1.96; its P/E ratio is ―; Soleno Therapeutics is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $0.92. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 190.41M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 187.71M$ 0.00$ -1.96M$ 0.00$ 0.00
Operating Income$ 14.95M$ -187.67M$ -41.38M$ -24.40M$ -31.53M
EBITDA$ 28.38M$ -173.63M$ -37.03M$ -22.10M$ -30.30M
Net Income$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Balance Sheet
Cash & Short-Term Investments$ 305.47M$ 291.44M$ 169.68M$ 14.60M$ 21.30M
Total Assets$ 563.83M$ 330.97M$ 180.69M$ 26.50M$ 35.55M
Total Debt$ 2.69M$ 52.83M$ 403.00K$ 155.00K$ 457.00K
Net Debt$ -67.42M$ -35.10M$ -169.28M$ -14.45M$ -20.85M
Total Liabilities$ 113.72M$ 85.86M$ 23.18M$ 16.15M$ 17.76M
Stockholders' Equity$ 450.12M$ 245.11M$ 157.51M$ 10.35M$ 17.79M
Cash Flow
Free Cash Flow$ 46.73M$ -69.31M$ -24.94M$ -20.79M$ -27.79M
Operating Cash Flow$ 46.80M$ -69.10M$ -24.94M$ -20.78M$ -27.77M
Investing Cash Flow$ -201.78M$ -225.68M$ 0.00$ -13.00K$ -22.00K
Financing Cash Flow$ 137.16M$ 213.03M$ 180.02M$ 14.09M$ -128.00K
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Income Statement >

Soleno Therapeutics Debt to Assets

Balance Sheet >

Soleno Therapeutics Cash Flow

Cash Flow >

Soleno Therapeutics Forecast EPS vs Actual EPS

Earnings >